102 related articles for article (PubMed ID: 16273275)
1. Time-dependent RNA degradation affecting cDNA array quality in spontaneous canine tumours sampled using standard surgical procedures.
Von Euler H; Khoshnoud R; He Q; Khoshnoud A; Fornander T; Rutqvist LE; Skog S
Int J Mol Med; 2005 Dec; 16(6):979-85. PubMed ID: 16273275
[TBL] [Abstract][Full Text] [Related]
2. cDNA microarray profiles of canine mammary tumour cell lines reveal deregulated pathways pertaining to their phenotype.
Rao NA; van Wolferen ME; van den Ham R; van Leenen D; Groot Koerkamp MJ; Holstege FC; Mol JA
Anim Genet; 2008 Aug; 39(4):333-45. PubMed ID: 18462483
[TBL] [Abstract][Full Text] [Related]
3. A microarray study of post-mortem mRNA degradation in mouse brain tissue.
Catts VS; Catts SV; Fernandez HR; Taylor JM; Coulson EJ; Lutze-Mann LH
Brain Res Mol Brain Res; 2005 Aug; 138(2):164-77. PubMed ID: 15921819
[TBL] [Abstract][Full Text] [Related]
4. Expression of c-myc in canine mammary tumours.
Engström W; Barrios C; Azawedo E; Möllermark G; Kängström LE; Eliason I; Larsson O
Anticancer Res; 1987; 7(6):1235-7. PubMed ID: 2831793
[TBL] [Abstract][Full Text] [Related]
5. Gene expressions of canine angiopoietin-1 and -2 in normal tissues and spontaneous tumours.
Kato Y; Asano K; Mizutani I; Konno T; Sasaki Y; Kutara K; Teshima K; Edamura K; Kano R; Suzuki K; Shibuya H; Sato T; Hasegawa A; Tanaka S
Res Vet Sci; 2006 Oct; 81(2):280-6. PubMed ID: 16545849
[TBL] [Abstract][Full Text] [Related]
6. Derlin-1 and stanniocalcin-1 are differentially regulated in metastasizing canine mammary adenocarcinomas.
Klopfleisch R; Gruber AD
J Comp Pathol; 2009; 141(2-3):113-20. PubMed ID: 19515379
[TBL] [Abstract][Full Text] [Related]
7. Quantification of VEGF-C expression in canine mammary tumours.
Qiu C; Lin DD; Wang HH; Qiao CH; Wang J; Zhang T
Aust Vet J; 2008 Jul; 86(7):279-82. PubMed ID: 18616481
[TBL] [Abstract][Full Text] [Related]
8. A time course study demonstrating RNA stability in postmortem skin.
Gopee NV; Howard PC
Exp Mol Pathol; 2007 Aug; 83(1):4-10. PubMed ID: 17174950
[TBL] [Abstract][Full Text] [Related]
9. Expression of the PTEN tumor suppressor gene in malignant mammary gland tumors of dogs.
Kanae Y; Endoh D; Yokota H; Taniyama H; Hayashi M
Am J Vet Res; 2006 Jan; 67(1):127-33. PubMed ID: 16426222
[TBL] [Abstract][Full Text] [Related]
10. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
[TBL] [Abstract][Full Text] [Related]
11. Expression and significance of PTEN in canine mammary gland tumours.
Qiu C; Lin D; Wang J; Wang L
Res Vet Sci; 2008 Oct; 85(2):383-8. PubMed ID: 18082231
[TBL] [Abstract][Full Text] [Related]
12. RNA degradation in human breast tissue after surgical removal: a time-course study.
Ohashi Y; Creek KE; Pirisi L; Kalus R; Young SR
Exp Mol Pathol; 2004 Oct; 77(2):98-103. PubMed ID: 15351232
[TBL] [Abstract][Full Text] [Related]
13. Canine CD20 gene.
Kano R; Inoiue C; Okano H; Yamazaki J; Takahashi T; Watari T; Tokuriki M; Hasegawa A
Vet Immunol Immunopathol; 2005 Dec; 108(3-4):265-8. PubMed ID: 16061290
[TBL] [Abstract][Full Text] [Related]
14. Expression analysis and study of KLK4 in benign and malignant breast tumours.
Papachristopoulou G; Avgeris M; Scorilas A
Thromb Haemost; 2009 Feb; 101(2):381-7. PubMed ID: 19190825
[TBL] [Abstract][Full Text] [Related]
15. Canine mammary gland tumours; a histological continuum from benign to malignant; clinical and histopathological evidence.
Sorenmo KU; Kristiansen VM; Cofone MA; Shofer FS; Breen AM; Langeland M; Mongil CM; Grondahl AM; Teige J; Goldschmidt MH
Vet Comp Oncol; 2009 Sep; 7(3):162-72. PubMed ID: 19691645
[TBL] [Abstract][Full Text] [Related]
16. Analysis of mRNA from human heart tissue and putative applications in forensic molecular pathology.
Partemi S; Berne PM; Batlle M; Berruezo A; Mont L; Riuró H; Ortiz JT; Roig E; Pascali VL; Brugada R; Brugada J; Oliva A
Forensic Sci Int; 2010 Dec; 203(1-3):99-105. PubMed ID: 20705404
[TBL] [Abstract][Full Text] [Related]
17. Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma.
Dahl E; Wiesmann F; Woenckhaus M; Stoehr R; Wild PJ; Veeck J; Knüchel R; Klopocki E; Sauter G; Simon R; Wieland WF; Walter B; Denzinger S; Hartmann A; Hammerschmied CG
Oncogene; 2007 Aug; 26(38):5680-91. PubMed ID: 17353908
[TBL] [Abstract][Full Text] [Related]
18. Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma.
Fieten H; Spee B; Ijzer J; Kik MJ; Penning LC; Kirpensteijn J
Vet Pathol; 2009 Sep; 46(5):869-77. PubMed ID: 19429984
[TBL] [Abstract][Full Text] [Related]
19. Gene (mRNA) expression in canine atopic dermatitis: microarray analysis.
Merryman-Simpson AE; Wood SH; Fretwell N; Jones PG; McLaren WM; McEwan NA; Clements DN; Carter SD; Ollier WE; Nuttall T
Vet Dermatol; 2008 Apr; 19(2):59-66. PubMed ID: 18336422
[TBL] [Abstract][Full Text] [Related]
20. Increased survival in dogs with malignant mammary tumours overexpressing HER-2 protein and detection of a silent single nucleotide polymorphism in the canine HER-2 gene.
Hsu WL; Huang HM; Liao JW; Wong ML; Chang SC
Vet J; 2009 Apr; 180(1):116-23. PubMed ID: 18061495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
